Xaira Therapeutics announced the appointment of Dr. Debbie Law to its C-suite. Law will serve as chief scientific officer.
Xaira Therapeutics launched in April on...
Leyden Laboratories B.V., a biotechnology company working to free people from the threat of respiratory viruses by boosting mucosal immunity, announced the appointment of...
Boehringer Ingelheim and OSE Immunotherapeutics SA (OSE), a clinical stage biotech company, announced that Boehringer will be progressing their first-in-class SIRPα immuno-oncology program into...
I-Mab, a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer, announced...
Thermo Fisher Scientific, the global leader in serving science, and Arsenal Biosciences, Inc. , a cell therapy clinical development company, to develop novel chimeric...
